MedTrace Logo

Endothelial Dysfunction in Resuscitated Cardiac Arrest

NCT02685618 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-03-10

No results posted yet for this study

Summary

Objective: Safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome (PCAS) patients.

Conditions

  • Cardiac Arrest

Interventions

DRUG

Iloprost

DRUG

Saline

DEVICE

Phillips M1006B, offset by -10mmHg

Administration of blood pressure module M1006B: offset by -10 mmHg

DEVICE

Philips M1006B, No offset

Administration of blood pressure module M1006B: No offset

Sponsors & Collaborators

  • Pär Johansson

    lead OTHER

Principal Investigators

  • Chistian Hassager, MD, DMSc · Dept. of Cardiology, 2143, Rigshospitalet, Blegdamsvej 0, DK-2100

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-08-27
Completion
2017-02-27

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02685618 on ClinicalTrials.gov